TOP NEWS

Neuralieve Raises $3.89M

Sunnyvale-based Neuralieve, a developer of a medical device for relieving migraine pain, has raised $3.89M out of an ongoing $7.5M fundraise, according to a regulatory filing by the firm. Source of the new funding was not disclosed, however, Annette Campbell-White of MedVenture Associates sits on the firm's board of directors. The firm had previously raised funding from New Enterprise Associates, Domain Associates, and Johnson and Johnson Development Corp. More information »


LATEST HEADLINES

More Headlines

BROWSE ISSUES